Re-inventing tumor targeting
Thermosome is a drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy. At its core is a new tumor targeting concept, which allows for increased local drug concentrations to achieve improved clinical treatment efficacy.
Latest news
Thermosome Receives U.S. Orphan Drug Designation for Lead Compound THE001, Expands Patent Estate
BIO International Convention
June 16-19, 2025
Boston, USA
